Delivery Order SPE2DR25D2005-SPE2DR26FE7Z0
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,591.94 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 80 mg/0.8 mls, a pharmaceutical product used in the treatment of autoimmune conditions. This firm fixed-price contract, issued on November 10, 2025, with an ultimate completion date of November 12, 2025, was competitively awarded with no set-aside designation. The product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's...
- The Defense Logistics Agency awarded a $12,360.33 delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, a pharmaceutical product used in the treatment of autoimmune conditions. This firm fixed-price, non-competitive set-aside contract is scheduled for completion by December 8, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- The Defense Logistics Agency has awarded a delivery order valued at $13,635.57 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, a pharmaceutical product used in the treatment of autoimmune conditions. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by October 16, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work from...
- The Defense Logistics Agency awarded a delivery order valued at $4,775.88 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mL, a pharmaceutical product used to treat autoimmune conditions. The award, issued December 8, 2025, with an ultimate completion date of December 9, 2025, utilizes firm fixed pricing under a non-set-aside competitive procurement. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $9,883.66 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, a pharmaceutical product used in the treatment of autoimmune conditions. The award, issued on June 12, 2025, with an ultimate completion date of June 13, 2025, represents a non-competitive, single-award delivery order under an existing contract vehicle. The place of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $2,039.08 to AmerisourceBergen Drug Corp for the supply of HUMIRA Pen 40 mg/0.8 mL, a pharmaceutical product used in the treatment of autoimmune conditions. This firm fixed price delivery order, issued on October 23, 2025, with an ultimate completion date of October 24, 2025, represents a competitive award with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,784.59 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of autoimmune conditions. This firm fixed-price delivery order, issued on October 16, 2025, with completion expected by October 17, 2025, was awarded without set-aside restrictions through competitive procurement. The product will be delivered to the company's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $4,878.00 to supply HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used to treat autoimmune conditions. The award, issued on October 27, 2025, represents a firm fixed-price delivery order with an ultimate completion date of October 28, 2025. This contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken,...
- The Defense Logistics Agency awarded a $2,719.71 delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of HUMIRA (CF) Pen 40 MG/0.4 MLS, a pharmaceutical product for treating autoimmune conditions. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September...
- The Defense Logistics Agency awarded a delivery order valued at $32,216.41 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used to treat various inflammatory conditions. This firm fixed-price delivery order, with an ultimate completion date of September 24, 2025, was competitively awarded without set-aside restrictions. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the...
- SPE2DR25D2005Indefinite Delivery Contract
- SPE2DR25D2005-SPE2DR26FE7Z0Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $12,704.63 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of autoimmune conditions. The contract is a firm fixed price delivery order with no set-aside designation, reflecting an open and competitive award process. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order for delivery to its corporate office location in Conshohocken, PA. The award date is December 3, 2025, with an ultimate completion date of December 4, 2025, indicating a rapid fulfillment timeline. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency and U.S. Coast Guard. The company's consistent receipt of competitive delivery orders for diverse pharmaceutical products demonstrates its established capability to meet federal medical procurement requirements efficiently.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.7k | 12/2/25 |